Similar articles

• High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

  Berardi S, Lodato F, Gramenzi A, D'Errico A, Lenzi M, Bontadini A, Morelli MC, Tamè MR, Piscaglia F, Biselli M, Sama C, Mazzella G, Pinna AD, Grazi G, Bernardi M, Andreone P. Berardi S, et al. Gut. 2007 Feb;56(2):237-42. doi: 10.1136/gut.2006.092064. Epub 2006 Jun 23. Gut. 2007. PMID: 16798778 Free PMC article.
• Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.

  Ikegami T, Wang H, Yoshizumi T, Toshima T, Aishima S, Fukuhara T, Furusyo N, Kotoh K, Shimoda S, Shirabe K, Maehara Y. Ikegami T, et al. Hepatol Int. 2014 Apr;8(2):285-92. doi: 10.1007/s12072-013-9496-2. Epub 2013 Dec 27. Hepatol Int. 2014. PMID: 26202510
• Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.

  Stravitz RT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Heuman DM, Ashworth A, Mills AS, Contos M, Cotterell AH, Maluf D, Posner MP, Fisher RA. Stravitz RT, et al. Liver Transpl. 2004 Jul;10(7):850-8. doi: 10.1002/lt.20189. Liver Transpl. 2004. PMID: 15237368
• Treatment of recurrent hepatitis C.

  Gane E. Gane E. Liver Transpl. 2002 Oct;8(10 Suppl 1):S28-37. doi: 10.1053/jlts.2002.35860. Liver Transpl. 2002. PMID: 12362295 Review.
• Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.

  Ueda Y, Uemoto S. Ueda Y, et al. Transplantation. 2016 Jan;100(1):54-60. doi: 10.1097/TP.0000000000000860. Transplantation. 2016. PMID: 26335914 Review.